Accurate identification between central nervous system lymphoma (CNSL) and high-grade glioma (HGG) has a great impact on the clinical treatment planning of the patients. This study uses the histogram analysis of dynamic contrast-enhanced (DCE) MRI to distinguish CNSL and HGG. Histogram features based on DCE pharmacokinetic parameters were used and achieved high diagnostic efficiency, which provides imaging features for guiding clinical treatment.
This abstract and the presentation materials are available to members only; a login is required.